-
With the advent of specific genetic tests, atypical forms of facioscapulohumeral muscular dystrophy can be reliably diagnosed.
-
Vorapaxar is a potent antiplatelet medication with a novel action that works by inhibiting thrombin activation of platelets through the protease-activated receptor PAR-1.
-
-
Drug shortages; metformin and cancer prevention; migraine prevention guidelines; and FDA actions.
-
Based on a retrospective analysis of 77 patients with monophasic and recurrent inflammatory spinal cord disease, the authors report significantly lower vitamin D levels in patients with recurrent disease.
-
Isoflurane causes mitochondrial disruption and apoptosis in neuronal and hippocampal cells, and decreases memory consolidation in mice. Such effects are not seen with desflurane. This may impact selection of anesthetic agents for patients with Alzheimer's disease undergoing surgical procedures.
-
The clinicopathological features of nine patients with pure autonomic neuropathy, with or without antiganglionic acetylcholine antibody, were assessed. There was considerable variability in the clinical manifestations, course, unmyelinated nerve fiber loss, and response to therapy.
-
Children with isolated growth hormone deficiency have lower IQ, worse motor skills, and several brain regions with smaller volumes than carefully selected controls.
-
Of all ischemic stroke patients treated with iv al- teplase (tPA), only about half will achieve recanalization and have a good outcome (mRS 0 to 2).
-
Needle EMG is safe in patients who are taking therapeutic doses of antiplatelet or anticoagulant medications.
